Overview

Pharmacokinetics of Low Dose Ritonavir

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
Compare the Pharmacokinetics of ritonavir and saquinavir(using either Saquinavir /Ritonavir 1500/100 mg or 1500/50 mg) Evaluate short term tolerability, safety and toxicity Evaluate if there is any relation between RTV concentration levels and boosting effect
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
The HIV Netherlands Australia Thailand Research Collaboration
Treatments:
Ritonavir
Saquinavir